Benjamin T. Dake, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 40,000 shares at $17.80 ($707K) on 2022-12-06, disclosed to the SEC on 2022-12-08.
Open-market sale of $707k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.61 | 2,011 | $31K | 4.4% |
| 2 | $16.90 | 1,259 | $21K | 3.0% |
| 3 | $17.80 | 36,115 | $643K | 91.0% |
| 4 | $18.29 | 615 | $11K | 1.6% |
| Total | $17.67 avg | 40,000 | $707K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-28 | $619K | — | Filing → |
| AVTE | SELL | 2024-03-27 | $192K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $1.8M | — | Filing → |